Article
Vitamin D receptor gene polymorphism and vitamin D supplementation on clinical/ treatment outcome in tuberculosis: current and future perspectives.
Expert review of anti-infective therapy - 1 Sept 2022
Sekhar Miraj Sonal, Vyas Navya, Kurian Shilia Jacob, Baral Tejaswini, Thomas Levin, Reddy B Shrikar, Munisamy Murali, Banerjee Mithu, Rao Mahadev
Abstract excerpt
INTRODUCTION: Tuberculosis (TB) is a transnational public health concern, which requires more precise treatment strategies than the existing approaches. Vitamin D modulates the inflammatory and immune response to the disease. Robust evidence shows that vitamin D deficiency and its receptor gene polymorphism influence the susceptibility to TB and the outcome of the anti-tubercular treatment (ATT). However, in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
